These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9005265)

  • 1. Elevated lipoprotein(a) and premature coronary heart disease.
    Haider AW
    JAMA; 1997 Jan; 277(3):209-10; author reply 210. PubMed ID: 9005265
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipoprotein(a) and fibrinolysis.
    Hegele RA
    Can J Cardiol; 1992 Dec; 8(10):1021-2. PubMed ID: 1288832
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum Lp(a) lipoprotein concentration and outcome of thrombolytic treatment for myocardial infarction.
    MBewu AD; Durrington PN; Mackness MI; Hunt L; Turkie WH; Creamer JE
    Br Heart J; 1994 Apr; 71(4):316-21. PubMed ID: 8198880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lipoprotein(a): epidemiology and therapeutic approaches].
    Kassner U; Thomas HP; Steinhagen-Thiessen E
    Dtsch Med Wochenschr; 2000 Nov; 125(44):1337-43. PubMed ID: 11109417
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum lipoprotein(a) level is related to thrombin generation and spontaneous intermittent coronary occlusion in patients with acute myocardial infarction.
    Haider AW; Andreotti F; Thompson GR; Kluft C; Maseri A; Davies GJ
    Circulation; 1996 Nov; 94(9):2072-6. PubMed ID: 8901653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of lipoprotein-a on thrombolytic therapy and spontaneous reperfusion in acute myocardial infarction. A comparative study.
    Dagdelen S; Eren N; Akdemir I; Karabulut H; Ergelen M; Caglar N
    Int Angiol; 2002 Dec; 21(4):384-9. PubMed ID: 12518121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation of lipoprotein(a) plasma levels after premature myocardial infarction.
    Goliasch G; Wiesbauer F; Blessberger H; Maurer G; Derfler K; Speidl WS
    Int J Cardiol; 2015; 186():5-6. PubMed ID: 25804454
    [No Abstract]   [Full Text] [Related]  

  • 8. Does increased lipoprotein (a) impair the effectiveness of thrombolysis with streptokinase?
    Tokgözoğlu SL; Ozmen F; Kabukçu M; Karanfil A; Aytemir K; Ozkuyumcu C; Uğurlu S
    Angiology; 1995 Aug; 46(8):727-31. PubMed ID: 7639420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated lipoprotein(a) and premature coronary heart disease.
    Parsons WB
    JAMA; 1997 Jan; 277(3):209; author reply 210. PubMed ID: 9005264
    [No Abstract]   [Full Text] [Related]  

  • 10. Elevated lipoprotein(a) and premature coronary heart disease.
    Maher VM; Brown BG
    JAMA; 1997 Jan; 277(3):209; author reply 210. PubMed ID: 9005263
    [No Abstract]   [Full Text] [Related]  

  • 11. [Lipoprotein (a) in coronary heart disease and myocardial infarction].
    Wottawa A; Fromme K; Klein G
    MMW Munch Med Wochenschr; 1984 Jan; 126(3):53-5. PubMed ID: 6230531
    [No Abstract]   [Full Text] [Related]  

  • 12. Lipoprotein(a) concentrations are increased in patients with myocardial infarction and angiographically normal coronary arteries.
    Graziani MS; Zanolla L; Righetti G; Nicoli M; Modena N; Dimitri G; Menegatti G; Vassanelli C
    Eur J Clin Chem Clin Biochem; 1993 Mar; 31(3):135-7. PubMed ID: 8490059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein (a) blood levels in unstable angina pectoris, acute myocardial infarction, and after thrombolytic therapy.
    Qiu SQ; Théroux P; Genest J; Solymoss BC; Robitaille D; Marcil M
    Am J Cardiol; 1991 Jun; 67(15):1175-9. PubMed ID: 1827942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiplatelet therapy in coronary heart disease. Emerging strategies for the treatment and prevention of acute myocardial infarction.
    Becker RC
    Arch Pathol Lab Med; 1993 Jan; 117(1):89-96. PubMed ID: 8418769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of association between raised serum Lp(a) concentration and unsuccessful thrombolysis after acute myocardial infarction.
    Armstrong VW; Neubauer C; Schütz E; Tebbe U
    Lancet; 1990 Oct; 336(8722):1077. PubMed ID: 1977059
    [No Abstract]   [Full Text] [Related]  

  • 16. Extreme lipoprotein(a) levels and improved cardiovascular risk prediction.
    Kamstrup PR; Tybjærg-Hansen A; Nordestgaard BG
    J Am Coll Cardiol; 2013 Mar; 61(11):1146-56. PubMed ID: 23375930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated serum concentrations of soluble adhesion molecules in coronary artery disease and acute myocardial infarction.
    Zeitler H; Ko Y; Zimmermann C; Nickenig G; Glänzer K; Walger P; Sachinidis A; Vetter H
    Eur J Med Res; 1997 Sep; 2(9):389-94. PubMed ID: 9300936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High lipoprotein(a) in children from kindreds with parental premature myocardial infarction.
    Marquez A; Mendoza S; Carrasco H; Hamer T; Glueck CJ
    Pediatr Res; 1993 Nov; 34(5):670-4. PubMed ID: 8284108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated serum Lp(a) concentration and the rare apo(a) phenotype in a patient with myocardial infarction.
    Hibino T; Sakuma N; Hashimoto T; Ohte N; Yoneyama A; Satoh T; Fujinami T
    Clin Cardiol; 1996 Sep; 19(9):758-9. PubMed ID: 8874999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein (a) in subjects with or without coronary artery disease: relation to clinical history and risk factors.
    Maranhão RC; Vinagre CG; Arie S; Guimarães JB; da-Luz P; Bellotti G; Pileggi F
    Braz J Med Biol Res; 1995 Apr; 28(4):439-46. PubMed ID: 8520541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.